- Home
- POST vs BBIO Comparison
POST vs BBIO Comparison
Compare POST & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POST
- BBIO
- Stock Information
- Founded
- POST 1895
- BBIO 2015
- Country
- POST United States
- BBIO United States
- Employees
- POST N/A
- BBIO N/A
- Industry
- POST Packaged Foods
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- POST Consumer Staples
- BBIO Health Care
- Exchange
- POST Nasdaq
- BBIO Nasdaq
- Market Cap
- POST 6.5B
- BBIO 5.6B
- IPO Year
- POST N/A
- BBIO 2019
- Fundamental
- Price
- POST $111.40
- BBIO $32.22
- Analyst Decision
- POST Buy
- BBIO Strong Buy
- Analyst Count
- POST 6
- BBIO 11
- Target Price
- POST $127.17
- BBIO $52.20
- AVG Volume (30 Days)
- POST 622.3K
- BBIO 3.7M
- Earning Date
- POST 05-01-2025
- BBIO 05-01-2025
- Dividend Yield
- POST N/A
- BBIO N/A
- EPS Growth
- POST 30.34
- BBIO N/A
- EPS
- POST 6.07
- BBIO N/A
- Revenue
- POST $7,931,500,000.00
- BBIO $221,902,000.00
- Revenue This Year
- POST $2.79
- BBIO $6.31
- Revenue Next Year
- POST $1.71
- BBIO $131.17
- P/E Ratio
- POST $18.49
- BBIO N/A
- Revenue Growth
- POST 7.32
- BBIO 2285.27
- 52 Week Low
- POST $99.62
- BBIO $21.62
- 52 Week High
- POST $125.84
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- POST 47.60
- BBIO 47.04
- Support Level
- POST $111.85
- BBIO $30.55
- Resistance Level
- POST $119.17
- BBIO $35.20
- Average True Range (ATR)
- POST 2.57
- BBIO 1.77
- MACD
- POST -0.17
- BBIO -0.37
- Stochastic Oscillator
- POST 6.91
- BBIO 27.25
About POST Post Holdings Inc.
Post Holdings Inc is an consumer packaged goods holding company. It operates in Post Consumer Brands which Includes branded and private label ready-to-eat cereals, Weetabix Includes the businesses of Weetabix Limited, which Post acquired in July 2017 and which produces and distributes branded and private label RTE cereal, hot cereals and other cereal-based food products, Foodservice which Includes egg and potato products in the foodservice and food ingredient channels from the businesses of MFI Holding Corporation, lastly Refrigerated Retail segment Provides refrigerated retail products, inclusive of side dishes, eggs and egg products, sausage, cheese and other dairy and refrigerated products.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.